Meeting
2018 ASCO Annual Meeting
Nasopharengeal carcinoma in children: Demographic, clinical, therapeutic characteristics and long term outcome of 97 patients.
Authors
Rejin Kebudi
Istanbul University, Cerrahpasa Faculty of Medicine and Oncology Institute, Pediatric Hematology-Oncology, Istanbul, Turkey
Rejin Kebudi , Musa Altun , Sema Bay Buyukkapu , Omer Gorgun , Rasim Meral , Inci Ayan , Bulent Zulfikar , Fulya Yaman Agaoglu , Emin Darendeliler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10547)
DOI
10.1200/JCO.2018.36.15_suppl.10547
Abstract #
10547
Poster Bd #
220
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC).
First Author: Winston Wong
Poster
2019 ASCO Annual Meeting
Impact of adjuvant chemotherapy and cumulative cisplatin dose in locally-advanced nasopharyngeal carcinoma (LA-NPC) treated with definitive chemoradiotherapy.
First Author: Marc Oliva Bernal
Poster
2014 ASCO Annual Meeting
Comparative effectiveness of contemporary adjuvant chemotherapy among older rectal cancer patients.
First Author: Jennifer Leigh Lund
Poster
2014 ASCO Annual Meeting
Survival of good-risk germ cell tumor patients following post-chemotherapy retroperitoneal lymph node dissection: The effect of bleomycin during induction chemotherapy.
First Author: K. Clint Cary